OMGILI Obtains Seed Funding

Omgili Ltd. (www.omgili.com), an Israeli-based web search and research startup, announced today that it has obtained seed funding. The investors are Israeli-based venture capitalists Pitango Venture Capital.

Omgili is a web-based information services company. The company’s search and research services are based on advanced and proprietary discussion group search technologies. These services enable individuals, companies and institutions to effectively tap into the collective intelligence and experience of millions of people on the World Wide Web, and derive valuable information, knowledge, conclusions and insights.

The funding enables Omgili to upscale its search and storage

capabilities to the dimensions needed in order to cover the lion’s share of relevant online information on a daily basis, to pursue its plans to commercialize its technology and will take the company to a planned first round of funding.

 

“Omgili search is rapidly growing in popularity, which confirms our belief that people can really benefit from knowing what other people are saying. Omgili’s mission is to harness the infinite power of ‘many to many’ web communication platforms for the benefit of our customers,” said Ran Geva, CEO of Omgili Ltd. “User Generated Content is a vast sea of knowledge and experience that is now at everyone’s disposal.”

Omgili search is based on proprietary and patent protected search technology which allows it to identify online discussions and differentiate between discussion components like titles, topics, posts, replies and dates.

Geva adds, “Our advanced search capabilities will allow us to develop cutting edge marketing research tools that will allow marketers worldwide to actually listen to what their consumers are saying about their brands and products, in an unbiased and unsolicited environment.”

Rona Segev-Gal, General Partner at Pitango Venture Capital: “We found Omgili to be a technologically innovative company that’s bringing something genuinely new to the online search and research space. Omgili’s technology will enable marketing professionals to actually be connected to their consumers needs, in real time.”

Segev-Gal emphasized that the investment in Omgili is part of Pitango’s strategy to grant seed funding to companies at their very early stages.

About Omgili Ltd.
Omgili was founded in April 2007 by the entrepreneurs Ran Geva and Israel tzadok. The name Omgili is derived from the initials of the expression “Oh My God I Love It!” which is what the application developers think of it’s technology — The best way in the known universe to find out what people are saying about anything and everything.

Omgili is a vertical search engine that focuses on “many to many” user generated content platforms, such as, forums, Discussion groups, answer boards and others.

Omgili is a crawler based, vertical search engine that scans tens of millions of online discussions worldwide in hundreds of thousands of boards and forums, and is able to differentiate between discussion entities, such as title, topic, answer and post date.

Omgili is your way to find consumer opinions, debates, discussions, personal experiences, answers and solutions. Most of the questions have already been answered – find the answers through Omgili. Most of the technical problems have been solved — find the solutions through Omgili. Most of the experiences have already been described — Find these descriptions through Omgili.

Omgili is a company that believes in the power of discussion and in the benefit of listening. We are dedicated to promoting the online discussion and to making it work for the general good.

About Pitango Venture Capital www.pitango.com
Pitango Venture Capital has been investing in technology entrepreneurs since 1993. Pitango currently manages several venture funds totalling over $1 billion in committed capital invested in more than 100 companies. Pitango invests in high-growth companies in seed and early stages, supporting them as they grow. Pitango focuses on the IT/Communication sectors, as well as in Life Sciences, including Medical Devices and Biotech.